Table 1 Baseline demographic characteristics and clinical features
|  | Total cohort (N = 100) | T1 of SE (n = 56) | T2 of SE (n = 44) | P value |
|---|---|---|---|---|
Demographics | ||||
 Gender, male | 61(61.0%) | 37(66.1%) | 24(54.5%) | 0.303 |
 Age, median (IQR), years | 66(53, 75) | 64.5(46.8, 73,8) | 67(56, 81.8) | 0.133 |
 History of prior seizures | 33(33.0%) | 20(35.7%) | 13(29.5%) | 0.530 |
SE semiology | Â | Â | Â | 0.314 |
 Tonic-clonic SE | 52(52.0%) | 32(57.1%) | 20(45.5%) | |
 Focal SE with impaired consciousness | 48(48.0%) | 24(42.9%) | 24(54.5%) | |
Seizure duration (IQR), min | 30(10–120) | 10(10–15) | 174.9(100.2–540) | <0.001 *** |
Etiology of SE | ||||
 Acute symptomatic | 50(50.0%) | 24(42.9%) | 26(59.1%) | 0.158 |
 Remote symptomatic | 30(30.0%) | 19(33.9%) | 11(25.0%) | 0.384 |
 Progressive symptomatic | 13(13.0%) | 7(12.5%) | 6(13.6%) | 0.999 |
 Unknown | 7(7.0%) | 6(10.7%) | 1(2.3%) | 0.131 |
Neuroimaging | ||||
 unilateral lesions | 31(31.0%) | 18(32.1%) | 13(29.5%) | 0.830 |
 bilateral lesions/diffuse cerebral edema | 49(49.0%) | 23(41.1%) | 26(59.1%) | 0.107 |
EEG features | ||||
 Interictal epileptiform activities | 39(39.0%) | 18(32.1%) | 21(47.7%) | 0.149 |
 Periodic patterns | 7(7.0%) | 4(7.1%) | 3(6.8%) | 0.999 |